Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biohit Oyj Board/Management Information 2016

Apr 26, 2016

3304_rns_2016-04-26_c01c1f9f-2451-4798-b4f2-4b4ab84c1518.html

Board/Management Information

Open in viewer

Opens in your device viewer

Disclosure 332397

Biohit Oyj - Company Announcement

Constitutive meeting of Biohit Oyj’s Board of Directors

Biohit Oyj Stock Exchange Release April 26, 2016 at 9:30 AM local time (EEST) Biohit Oyj’s Board of Directors has in its meeting yesterday elected Mr Osmo Suovaniemi as the Chairman of the Board of Directors. Additional information: CEO Semi Korpela, Biohit Oyj tel. +358 9 773 861 [email protected] www.biohithealthcare.com Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com